ftInvstr
BLUEJET · Healthcare ₹571.2 -1.58% Mkt Cap ₹9919 Cr

BLUEJET

Healthcare Biotechnology
₹571.2
-1.58% today · 30d -2.84%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for BLUEJET. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹293 Cr
-17.38% YoY
NET PROFIT
₹78 Cr
-14.16% YoY
OPM
36.75%
+1.14pp YoY
EPS
₹4.51
PE 41.97
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-41.8%, h2=-46.5%, h3=-37.8% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
BLUEJET41.97
BIOCON154.516.88
ANTHEM91.3531.1
ONESOURCE5.79
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
55
SCORE / 100
Overall
6-axis composite of the sections below.
Performance NEUTRAL 40
Valuation FAIR 40
Growth MUTED 32
Profitability HIGH 90
Technicals NEUTRAL 57
Risk LOW 70
Key Stats
TTM PE
41.97
P/B
7.26
52W HIGH
₹789.0
OFF HIGH
-27.6%
DIV YIELD
0.21%
MKT CAP
₹9919 Cr
◉ Active Signals
MACDBearish-3.0603
RSI(14)Neutral42.43
Street Consensus
5 analysts
₹568.0
mean target
Low ₹370.0Now ₹571.2High ₹720.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold BLUEJET and at what entry.

Sign up freeSign in